Quick Answer
Adicet Bio, Inc. reported Stockholders Equity of $159.21 million for fiscal year 2025.
Adicet Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $159.21M | -14.7% |
| 2024 | $186.61M | +9.7% |
| 2023 | $170.18M | -41.8% |
| 2022 | $292.34M | -3.6% |
| 2021 | $303.13M | +176.0% |
| 2020 | $109.83M | +281.9% |
| 2019 | -$60.37M | -80.1% |
| 2018 | -$33.52M | -24.4% |
| 2017 | -$26.95M | — |
| 2016 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $109.14M | -48.4% | -18.2% |
| June 30, 2025 | $133.37M | -43.3% | -17.4% |
| March 31, 2025 | $161.45M | -37.6% | -13.5% |
| December 31, 2024 | $186.61M | +9.7% | -11.8% |
| September 30, 2024 | $211.53M | +8.7% | -10.0% |
| June 30, 2024 | $235.11M | -1.7% | -9.2% |
| March 31, 2024 | $258.80M | -2.8% | +52.1% |
| December 31, 2023 | $170.18M | -41.8% | -12.6% |
- Adicet Bio, Inc. showed a decrease of -14.7% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Adicet Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: